HIV-associated cancers

Clinical trials for HIV-associated cancers explained in plain language.

Never miss a new study

Get alerted when new HIV-associated cancers trials appear

Sign up with your email to follow new studies for HIV-associated cancers, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

HIV cancer hope: immune combo shows early promise but trial halted

Disease control Stopped early

This early-phase trial tested two immunotherapy drugs, ipilimumab and nivolumab, in people with HIV who had advanced solid tumors or Hodgkin lymphoma that had spread or come back. The goal was to find the safest dose and see if the combination could shrink tumors. The study was t…

Matched conditions: HIV-ASSOCIATED CANCERS

Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 08:13 UTC

HIV-associated cancers

Get alerted when new HIV-associated cancers trials appear

HIV cancer hope: immune combo shows early promise but trial halted